Atlas Trials

Hidradenitis Suppurativa (HS)

55 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Hidradenitis Suppurativa (HS)

RecordFirmDate
Hidradenitis Suppurativa Wound Care (NCT04354012)Wake Forest University Health Sciences2021-02-04
A Study of Oral Upadacitinib Tablet Compared to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa to Assess Change in Disease Symptoms (NCT04430855)AbbVie2020-07-14
Efficacy and Safety of Secukinumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa (NCT06926192)Peking Union Medical College2020-01-01
Observational Study Evaluating Long-Term Safety and Effectiveness of Humira in Patients With Hidradenitis Suppurativa (NCT03894956)AbbVie2019-05-02
Efficacy and Safety Study of IFX-1 in Patients With Moderate to Severe Hidradenitis Suppurativa (HS) (NCT03487276)InflaRx GmbH2018-02-26
Chronic Inflammatory Disease, Lifestyle and Treatment Response (NCT03173144)University of Southern Denmark2017-09-21
Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects (NCT03001115)AbbVie2017-03-10
Canadian Humira Post Marketing Observational Epidemiological Study : Assessing Humira Real-life Effectiveness and Impact on HS Burden of Illness (NCT02896920)AbbVie2016-09-20
Efficacy and Safety Study of Adalimumab in Treatment of Hidradenitis Suppurativa (NCT01468207)AbbVie (prior sponsor, Abbott)2011-11-01
Managed Access Programs for AIN457, Secukinumab (NCT05583604)Novartis Pharmaceuticals

Track Hidradenitis Suppurativa (HS) automatically

Every clearance here is in the API, with alerts when new ones post.